Variables | Model 1 | Model 2 | Model 3 | |||
---|---|---|---|---|---|---|
β (CI) | P | β (CI) | P | β (CI) | P | |
BMI |  |  | −0.395 (− 0.248, − 0.123) | 0.000 | − 0.287 (− 0.217, − 0.058) | 0.001 |
Lg (Albumin) |  |  | − 0.311 (−7.598, −2.465) | 0.000 | − 0.324 (−8.896, − 1.230) | 0.010 |
Lg (Prealbumin) |  |  | − 0.003 (− 0.813, 0.781) | 0.969 | 0.057 (− 1.104, 1.789) | 0.639 |
Male |  |  | 0.024 (− 0.478, 0.694) | 0.717 | 0.059 (− 0.400, 0.891) | 0.452 |
Age | Â | Â | 0.245 (0.023, 0.083) | 0.001 | 0.265 (0.021, 0.096) | 0.002 |
Married |  |  | 0.073 (−0.246, 0.930) | 0.252 | 0.091 (−0.273, 1.803) | 0.238 |
Secondary school or below |  |  | −0.030 (− 0.491, 0.306) | 0.647 | − 0.096 (− 0.808, 0.210) | 0.246 |
Employed |  |  | 0.098 (−0.111, 0.708) | 0.152 | 0.082 (−0.238, 0.723) | 0.319 |
Year since HIV diagnosis | −0.190 (− 0.326, 0.127) | 0.384 |  |  | −0.038 (− 0.232, 0.192) | 0.851 |
ART regimen | ||||||
 TDF-based regimen | 0.057 (−0.457, 0.812) | 0.580 |  |  | 0.038 (−0.404, 0.643) | 0.652 |
 AZT-based regimen | 0.121 (−0.492, 2.347) | 0.198 |  |  | 0.148 (−0.059, 2.314) | 0.062 |
 LPV/r-based regimen | 0.013 (−0.654, 0.742) | 0.900 |  |  | −0.022 (− 0.646, 0.490) | 0.786 |
Years of ART use | 0.012 (−0.226, 0.239) | 0.955 |  |  | −0.091 (− 0.261, 0.164) | 0.652 |
Comorbidities | ||||||
 Pneumonia | −0.160 (−1.216, 0.153) | 0.126 |  |  | −0.126 (−1.001, 0.163) | 0.156 |
 Hepatitis | −0.031 (− 1.260, 0.890) | 0.734 |  |  | −0.054 (−1.229, 0.599) | 0.495 |
 Tuberculosis | −0.154 (−2.189, 0.245) | 0.116 |  |  | −0.120 (−1.752, 0.242) | 0.136 |
 Diabetes | −0.015 (−1.385, 1.186) | 0.878 |  |  | −0.088 (−1.669, 0.465) | 0.265 |
 Syphilis | 0.115 (−0.594, 2.172) | 0.260 |  |  | 0.098 (−0.485, 1.836) | 0.251 |
 Cancer | 0.098 (−0.773, 2.494) | 0.298 |  |  | 0.084 (−0.624, 2.094) | 0.286 |
Lg (CD4 count) | −0.209 (−1.066, 0.025) | 0.061 |  |  | −0.041 (− 0.586, 0.384) | 0.680 |
Lg (RNA) | −0.181 (− 0.672, 0.031) | 0.074 |  |  | −0.186 (− 0.620, − 0.037) | 0.028 |